Acadian Asset Management LLC Atri Cure, Inc. Transaction History

Acadian Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$32.99 - $43.25 $209,750 - $274,983	6,358 Added 71.62%	15,235 $542,000
Q3 2023 Nov 13, 2023	BUY	$41.12 - $57.73 $62,707 - $88,038	1,525 Added 20.74%	8,877 $387,000
Q2 2023 Aug 07, 2023	BUY	$40.44 - $49.6 $297,314 - $364,659	7,352 New	7,352 $362,000
Q3 2019 Nov 07, 2019	SELL	$23.81 - $32.52 $110,073 - $150,339	-4,623 Closed	0 $0
Q2 2019 Aug 08, 2019	BUY	$26.85 - $30.74 $62,318 - $71,347	2,321 Added 100.83%	4,623 $138,000
Q1 2019 May 09, 2019	BUY	$26.38 - $33.34 $60,726 - $76,748	2,302 New	2,302 $62,000

211

49.6M

12K

7.2K

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.79B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.